Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs dexmedetomidine for sedation of acutely agitated elderly orthopedic ICU patients
ChiCTR2000036101Phase 4Not yet recruiting
- Sponsor
- Sichuan Provincial Orthopedic Hospital
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in postoperative delirium (POD) and delirium (2 arms), sponsored by Sichuan Provincial Orthopedic Hospital. Primary endpoints: Time to reach sedation target and Time to control agitation. Planned start Sep 2020; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
postoperative delirium (POD)delirium
Beyond the preview
Go deeper on ChiCTR2000036101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000036101.